Sintx technologies announces grant of new u.s patent for antibacterial applications of silicon nitride

Salt lake city, oct. 28, 2020 (globe newswire) -- sintx technologies, inc. ( www.sintx.com ) (nasdaq: sint) (“sintx” or the “company”), a manufacturer of silicon nitride ceramic for medical and non-medical applications, today announced that the united states patent and trademark office has issued us patent 10,806,831 covering antibacterial biomedical implants and associated materials. this newly issued patent broadly covers a variety of biomedical implants wherein the company's silicon nitride is applied to improve the antibacterial characteristics of the implant.
SINT Ratings Summary
SINT Quant Ranking